Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
The FDA announced the discontinuation of Allergan’s Byvalson (nebivolol/valsartan) tablets.
Return to publications